JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 23 No. 2 103-107
© 1982 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holm, L.-E.
Right arrow Articles by Dahlqvist, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holm, L.-E.
Right arrow Articles by Dahlqvist, I.

Incidence of Hypothyroidism Occurring Long after Iodine-131 Therapy for Hyperthyroidism

Lars-Erik Holm, Göran Lundell, Anders Israelsson and Ingemar Dahlqvist

Karolinska Hospital, Stockholm, Sweden

Correspondence: For reprints contact: L.-E. Holm, Dept. of General Oncology, Radiumhemmet, Karolinska Hospital, S-104 01 Stockholm, Sweden.

ABSTRACT

We have studied the long-term incidence of hypothyroidism in 4,473 formerly hyperthyroid patients given I-131 therapy between 1951 and 1975. The mean age at the first I-131 treatment was 56 yr. Six percent developed hypothyroidism within one year of therapy, and 72% within 26 yr. Prior antithyroid medication did not affect the incidence of hypothyroidism. Patients cured with one dose of I-131 had a lower cumulative long-term incidence of hypothyroidism than those requiring more than one dose.




This article has been cited by other articles:


Home page
BMJHome page
M. A Walter, M. Briel, M. Christ-Crain, S. J Bonnema, J. Connell, D. S Cooper, H. C Bucher, J. Muller-Brand, and B. Muller
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials
BMJ, March 10, 2007; 334(7592): 514 - 514.
[Abstract] [Full Text] [PDF]


Home page
Radiat Prot DosimetryHome page
H. Jonsson and S. Mattsson
Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism
Radiat Prot Dosimetry, January 15, 2004; 108(2): 107 - 114.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Bogazzi, L. Bartalena, A. Campomori, S. Brogioni, C. Traino, F. De Martino, G. Rossi, F. Lippi, A. Pinchera, and E. Martino
Treatment with Lithium Prevents Serum Thyroid Hormone Increase after Thionamide Withdrawal and Radioiodine Therapy in Patients with Graves' Disease
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4490 - 4495.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. A. Andrade, J. L. Gross, and A. L. Maia
The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves' Hyperthyroidism: One-Year Follow-Up of a Prospective, Randomized Study
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3488 - 3493.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. Nygaard, L. Hegedus, P. Ulriksen, K. G. Nielsen, and J. M. Hansen
Radioiodine Therapy for Multinodular Toxic Goiter
Arch Intern Med, June 28, 1999; 159(12): 1364 - 1368.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. E. Imseis, L. Vanmiddlesworth, J. D. Massie, A. J. Bush, and N. R. Vanmiddlesworth
Pretreatment with Propylthiouracil But Not Methimazole Reduces the Therapeutic Efficacy of Iodine-131 in Hyperthyroidism
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 685 - 687.
[Abstract] [Full Text]


Home page
NEJMHome page
J. A. Franklyn
The Management of Hyperthyroidism
N. Engl. J. Med., June 16, 1994; 330(24): 1731 - 1738.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1982 by the Society of Nuclear Medicine.